Weide B - Search Results

1

Pitfalls in the characterization of circulating and tissue-resident human γδ T cells.

Beucke N, Wesch D, Oberg HH, Peters C, Bochem J, Weide B, Garbe C, Pawelec G, Sebens S, Röcken C, Hashimoto H, Löffler MW, Nocerino P, Kordasti S, Kabelitz D, Schilbach K, Wistuba-Hamprecht K. Beucke N, et al. Among authors: weide b. J Leukoc Biol. 2020 Jun;107(6):1097-1105. doi: 10.1002/JLB.5MA1219-296R. Epub 2020 Jan 22. J Leukoc Biol. 2020. PMID: 31967358

2

Is morphoea caused by Borrelia burgdorferi? A review.

Weide B, Walz T, Garbe C. Weide B, et al. Br J Dermatol. 2000 Apr;142(4):636-44. doi: 10.1046/j.1365-2133.2000.03407.x. Br J Dermatol. 2000. PMID: 10792212 Review.

3

Imiquimod in the treatment of extensive recurrent lentigo maligna.

Kamin A, Eigentler TK, Radny P, Bauer J, Weide B, Garbe C. Kamin A, et al. Among authors: weide b. J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):51-2. doi: 10.1016/j.jaad.2004.07.047. J Am Acad Dermatol. 2005. PMID: 15692515

4

Plasmid DNA- and messenger RNA-based anti-cancer vaccination.

Weide B, Garbe C, Rammensee HG, Pascolo S. Weide B, et al. Immunol Lett. 2008 Jan 15;115(1):33-42. doi: 10.1016/j.imlet.2007.09.012. Epub 2007 Oct 26. Immunol Lett. 2008. PMID: 18006079 Review.

5

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

Weide B, Carralot JP, Reese A, Scheel B, Eigentler TK, Hoerr I, Rammensee HG, Garbe C, Pascolo S. Weide B, et al. J Immunother. 2008 Feb-Mar;31(2):180-8. doi: 10.1097/CJI.0b013e31815ce501. J Immunother. 2008. PMID: 18481387 Clinical Trial.

6

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

Weide B, Pascolo S, Scheel B, Derhovanessian E, Pflugfelder A, Eigentler TK, Pawelec G, Hoerr I, Rammensee HG, Garbe C. Weide B, et al. J Immunother. 2009 Jun;32(5):498-507. doi: 10.1097/CJI.0b013e3181a00068. J Immunother. 2009. PMID: 19609242 Clinical Trial.

7

Melanoma staging: facts and controversies.

Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, Meier F, Garbe C. Forschner A, et al. Among authors: weide b. Clin Dermatol. 2010 May-Jun;28(3):275-80. doi: 10.1016/j.clindermatol.2009.06.012. Clin Dermatol. 2010. PMID: 20541679

8

Incisional biopsy and melanoma prognosis: Facts and controversies.

Pflugfelder A, Weide B, Eigentler TK, Forschner A, Leiter U, Held L, Meier F, Garbe C. Pflugfelder A, et al. Among authors: weide b. Clin Dermatol. 2010 May-Jun;28(3):316-8. doi: 10.1016/j.clindermatol.2009.06.013. Clin Dermatol. 2010. PMID: 20541685 Review.

9

High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma.

Weide B, Derhovanessian E, Pflugfelder A, Eigentler TK, Radny P, Zelba H, Pföhler C, Pawelec G, Garbe C. Weide B, et al. Cancer. 2010 Sep 1;116(17):4139-46. doi: 10.1002/cncr.25156. Cancer. 2010. PMID: 20564107 Free article. Clinical Trial.

10

Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis.

Weide B, Zelba H, Derhovanessian E, Pflugfelder A, Eigentler TK, Di Giacomo AM, Maio M, Aarntzen EH, de Vries IJ, Sucker A, Schadendorf D, Büttner P, Garbe C, Pawelec G. Weide B, et al. J Clin Oncol. 2012 May 20;30(15):1835-41. doi: 10.1200/JCO.2011.40.2271. Epub 2012 Apr 23. J Clin Oncol. 2012. PMID: 22529253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page